FULLER H B CO
Business
H.B. Fuller Company is a worldwide formulator, manufacturer and marketer of adhesives, sealants and specialty chemical products. The company offers industrial adhesives for manufacturing and construction applications, including hygiene products, consumer goods, automotive, aerospace, electronics and construction markets, with sales operations across 34 countries. Operating segments include Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesives Solutions, serving customers through direct delivery from manufacturing facilities and distributor networks.
Summary from 10-K filed 2026-01-22
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-11-30 | FY 2024 2024-11-30 | FY 2023 2023-11-30 | FY 2022 2022-11-30 | FY 2021 2021-11-30 |
|---|---|---|---|---|---|---|
| Net revenue | 3,474 | 3,569 | 3,511 | 3,749 | 3,278 | |
| Cost of sales | −2,393 | −2,507 | −2,502 | −2,785 | −2,433 | |
| Gross profit | 1,081 | 1,062 | 1,009 | 964 | 845 | |
| Selling, general and administrative expenses | −726 | −714 | −654 | −641 | −593 | |
| Other Operating Income (Expense), Net | −11 | −37 | 10 | 13 | 33 | |
| Interest expense | −133 | −133 | −135 | −92 | −78 | |
| Interest income | 5 | 5 | 4 | 8 | 9 | |
| Income from continuing operations before income taxes and income from equity method investments | 215 | 183 | 234 | 252 | 217 | |
| Income tax expense | −67 | −56 | −94 | −77 | −63 | |
| Income from equity method investments | 4 | 4 | 4 | 6 | 8 | |
| Net income including non-controlling interest | 152 | 130 | 145 | 180 | 161 | |
| Net expense attributable to non-controlling interest | −106,000 | −139,000 | −82,000 | −94,000 | −82,000 | |
| Net income attributable to H.B. Fuller | 152 | 130 | 145 | 180 | 161 | |
| Basic (in dollars per share) | 2.78 | 2.37 | 2.67 | 3.37 | 3.05 | |
| Diluted (in dollars per share) | 2.75 | 2.3 | 2.59 | 3.26 | 2.97 | |
| Basic (in shares) | 55 | 55 | 54 | 54 | 53 | |
| Diluted (in shares) | 55 | 57 | 56 | 55 | 54 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-11-30 | FY 2024 2024-11-30 | FY 2023 2023-11-30 | FY 2022 2022-12-31 | FY 2022 2022-11-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 107 | 169 | 179 | 80 | 80 | |
| Trade receivables, net | 564 | 558 | 578 | 607 | 607 | |
| Inventories | 472 | 467 | 442 | 492 | 492 | |
| Other current assets | 120 | 104 | 113 | 120 | 120 | |
| Total current assets | 1,263 | 1,299 | 1,312 | 1,299 | 1,299 | |
| Property, Plant and Equipment, Net | 935 | 882 | 825 | — | 734 | |
| Goodwill | 1,680 | 1,532 | 1,487 | 1,393 | 1,393 | |
| Other intangibles, net | 806 | 770 | 729 | 702 | 702 | |
| Other assets | 498 | 450 | 371 | 336 | 336 | |
| Total assets | 5,183 | 4,933 | 4,724 | 4,464 | 4,464 | |
| Notes payable | 0 | 587,000 | 2 | 29 | 29 | |
| Accounts Payable, Current | 470 | 491 | 440 | 461 | 461 | |
| Accrued compensation | 114 | 106 | 96 | 108 | 108 | |
| Income taxes payable | 25 | 24 | 48 | 19 | 19 | |
| Accrued Liabilities, Current | 134 | 97 | 108 | 89 | 89 | |
| Total current liabilities | 743 | 719 | 693 | 706 | 706 | |
| Long-term debt, net of current maturities | 2,017 | 2,010 | 1,837 | 1,736 | 1,736 | |
| Accrued pension liabilities | 51 | 52 | 50 | 53 | 53 | |
| Other Liabilities, Noncurrent | 368 | 322 | 388 | 358 | 358 | |
| Total liabilities | 3,180 | 3,103 | 2,968 | 2,853 | 2,853 | |
| Commitments and contingencies (Note 14) | — | — | — | — | — | |
| Preferred stock (no shares outstanding) Shares authorized 10,045,900 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, par value $1.00 per share, Shares authorized 160,000,000, Shares outstanding 54,174,963 and 54,657,103 for 2025 and 2024, respectively | 54 | 55 | 54 | 54 | 54 | |
| Additional paid-in capital | 298 | 323 | 301 | 266 | 266 | |
| Retained earnings | 2,026 | 1,925 | 1,843 | 1,741 | 1,741 | |
| Accumulated other comprehensive loss | −375 | −473 | −443 | −451 | −451 | |
| Total H.B. Fuller stockholders' equity | 2,003 | 1,829 | 1,755 | 1,610 | 1,610 | |
| Non-controlling interest | −24,000 | 1 | 708,000 | 624,000 | 624,000 | |
| Total equity | 2,003 | 1,830 | 1,756 | 1,611 | 1,611 | |
| Total liabilities, non-controlling interest and total equity | 5,183 | 4,933 | 4,724 | 4,464 | 4,464 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-11-30 | FY 2024 2024-11-30 | FY 2023 2023-11-30 | FY 2022 2022-11-30 | FY 2021 2021-11-30 |
|---|---|---|---|---|---|---|
| Depreciation | 92 | 91 | 80 | 73 | 72 | |
| Amortization | 87 | 84 | 80 | 74 | 71 | |
| Deferred income taxes | −50 | −36 | −25 | −15 | 16 | |
| (Income) loss from equity method investments, net of dividends received | −13,000 | −537,000 | 1 | −9,000 | 3 | |
| (Gain) loss on disposal of assets | −4 | −501,000 | 59,000 | — | — | |
| Share-based compensation | 22 | 22 | 20 | 24 | 22 | |
| Loss on the sale of a business | 2 | 0 | 0 | — | — | |
| Loss on impairment of intangible asset | 924,000 | 0 | 0 | — | — | |
| Pension and other postretirement benefit plan contributions | −3 | −3 | −4 | −3 | −4 | |
| Pension and other postretirement benefit plan benefit | −21 | −14 | −19 | −24 | −29 | |
| Loss on impairment of assets held for sale | 0 | 47 | 0 | 0 | — | |
| Loss on impairment of equity investment | 0 | 2 | 0 | 0 | — | |
| Gain from insurance proceeds | 0 | −5 | 0 | 0 | — | |
| Debt issuance cost write-off | 0 | 0 | 3 | 0 | 0 | |
| (Gain) loss on fair value adjustment on contingent consideration liabilities | 0 | −500,000 | 3 | 0 | 2 | |
| Trade receivables, net | −3 | 11 | 69 | −25 | −125 | |
| Inventories | −10 | −30 | 73 | −56 | −135 | |
| Other assets | −29 | −17 | −8 | 46 | −79 | |
| Trade payables | −38 | 48 | −58 | −23 | 176 | |
| Accrued compensation | 5 | 13 | −14 | — | — | |
| Other accrued expenses | 36 | 6 | −3 | 6 | 1 | |
| Income taxes payable | −6 | −23 | 41 | −13 | −4 | |
| Other liabilities | 35 | −30 | 23 | 4 | −74 | |
| Foreign currency remeasurement | −2 | 10 | −28 | 6 | — | |
| Net cash provided by operating activities | 263 | 302 | 378 | 257 | 213 | |
| Purchased property, plant and equipment | −142 | −139 | −119 | −130 | −96 | |
| Purchased businesses, net of cash acquired | −167 | −274 | −205 | −251 | −5 | |
| Proceeds from the sale of a business | 76 | 0 | 0 | — | 0 | |
| Purchase of cost method investment | −3 | 0 | 0 | — | — | |
| Purchase of non-controlling interest | −1 | 0 | 0 | — | — | |
| Proceeds from sale of property, plant and equipment | 5 | 1 | 5 | 2 | 3 | |
| Proceeds from insurance recoveries | 0 | 5 | 0 | 0 | — | |
| Net cash used in investing activities | −232 | −407 | −319 | −375 | −95 | |
| Proceeds from issuance of long-term debt | 1,300 | 1,933 | 2,233 | 335 | 0 | |
| Repayment of long-term debt | −1,305 | −1,765 | −2,126 | −160 | −157 | |
| Payment of debt issue costs | −1 | −3 | −10 | −600,000 | 0 | |
| Net payment on notes payable | −587,000 | −1 | −29 | 3 | 9 | |
| Dividends paid | −50 | −48 | −43 | −39 | −35 | |
| Proceeds from stock options exercised | 10 | 36 | 15 | 30 | 32 | |
| Repurchases of common stock | −61 | −40 | −3 | −4 | −3 | |
| Contingent consideration payment | 0 | 0 | −1 | −5 | −2 | |
| Net cash (used in) provided by financing activities | −108 | 112 | 35 | 160 | −154 | |
| Net change in cash and cash equivalents | −62 | −10 | 100 | 18 | −39 | |
| Effect of exchange rate changes on cash and cash equivalents | 15 | −18 | 5 | −23 | −3 | |
| Dividends paid with company stock | 386,000 | 404,000 | 363,000 | 348,000 | 339,000 | |
| Cash paid for interest, net of amount capitalized of $562, $1,859, and $1,769 for the years ended November 29, 2025, November 30, 2024 and December 2, 2023, respectively | 133 | 135 | 137 | 84 | 63 | |
| Cash paid for income taxes, net of refunds | 125 | 123 | 71 | 73 | 73 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is FULLER H B CO's CIK number?
FULLER H B CO's SEC CIK number is 0000039368 (39368). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find FULLER H B CO's SEC filings?
All of FULLER H B CO's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did FULLER H B CO last report earnings?
FULLER H B CO (FUL) most recently filed an earnings 8-K with the SEC on Jun 25, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001437749-26-021622). This is FULLER H B CO's most recent earnings filing of record — not a forecast of its next earnings date.
What is FULLER H B CO's most recent earnings 8-K?
FULLER H B CO's latest earnings 8-K (Item 2.02) was filed Jun 25, 2026 under accession 0001437749-26-021622. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View FULLER H B CO's latest earnings 8-K →
Look up any company's CIK number →